DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Patel K, Harrison SA, Elkashab M. et al.
Cilofexor, a nonsteroidal FXR agonist, in non-cirrhotic patients with nonalcoholic steatohepatitis: a phase 2 randomized controlled trial.
Hepatology 2020;
72 (01) 58-71
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.